The estimated Net Worth of Robert Forrester is at least $614 millier dollars as of 27 September 2018. Robert Forrester owns over 10,500 units of Verastem Inc stock worth over $613,855 and over the last 13 years Robert sold VSTM stock worth over $0.
Robert has made over 9 trades of the Verastem Inc stock since 2013, according to the Form 4 filled with the SEC. Most recently Robert bought 10,500 units of VSTM stock worth $73,500 on 27 September 2018.
The largest trade Robert's ever made was buying 10,500 units of Verastem Inc stock on 27 September 2018 worth over $73,500. On average, Robert trades about 672 units every 60 days since 2012. As of 27 September 2018 Robert still owns at least 219,234 units of Verastem Inc stock.
You can see the complete history of Robert Forrester stock trades at the bottom of the page.
Robert's mailing address filed with the SEC is C/O VERASTEM, INC.,, 117 KENDRICK STREET, SUITE 500, NEEDHAM, MA, 02494.
Over the last 13 years, insiders at Verastem Inc have traded over $5,883,823 worth of Verastem Inc stock and bought 3,873,819 units worth $28,318,633 . The most active insiders traders include Capital Management, L.P.Ra ..., Christoph H Westphal et Ansbert Gadicke. On average, Verastem Inc executives and independent directors trade stock every 28 days with the average trade being worth of $112,479. The most recent stock trade was executed by Dan Paterson on 5 August 2024, trading 3,245 units of VSTM stock currently worth $7,009.
verastem, inc. (nasdaq: vstm) is a biopharmaceutical company focused on discovering and developing novel drugs that selectively target cancer stem cells. cancer stem cells are an underlying cause of tumor recurrence and metastasis. verastem is translating breakthrough discoveries in cancer stem cell research into new medicines for the treatment of major cancers such as breast cancer. for more information, please visit www.versatem.com
Verastem Inc executives and other stock owners filed with the SEC include: